Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.7M Sell
1,536,000
-56,000
-4% -$1.11M 0.4% 38
2026
Q1
$24.2M Sell
1,592,000
-408,000
-20% -$7.09M 0.43% 46
2025
Q4
$40.1M Hold
2,000,000
0.48% 33
2025
Q3
$48.4M Buy
2,000,000
+164,000
+9% +$4.34M 0.72% 20
2025
Q2
$48.6M Sell
1,836,000
-262,000
-12% -$6.82M 0.84% 13
2025
Q1
$57M Buy
2,098,000
+127,793
+6% +$4.69M 0.85% 17
2024
Q4
$80.1M Buy
1,970,207
+94,207
+5% +$3.4M 1.09% 13
2024
Q3
$53.9M Buy
1,876,000
+1,153,418
+160% +$41.6M 0.86% 22
2024
Q2
$31.9M Buy
722,582
+261,476
+57% +$13.6M 0.4% 45
2024
Q1
$28.6M Buy
461,106
+273,106
+145% +$19M 0.38% 42
2023
Q4
$14.8M Sell
188,000
-36,290
-16% -$2.53M 0.2% 69
2023
Q3
$14.4M Buy
224,290
+100,290
+81% +$7.51M 0.22% 73
2023
Q2
$10.2M Sell
124,000
-24,000
-16% -$1.61M 0.15% 96
2023
Q1
$10.7M Buy
+148,000
New +$10.6M 0.15% 88
2022
Q3
Sell
-65,000
Closed -$5.92M 216
2022
Q2
$5.92M Buy
+65,000
New +$6.58M 0.1% 99
2022
Q1
Sell
-75,000
Closed -$10.3M 155
2021
Q4
$10.3M Buy
+75,000
New +$11.1M 0.17% 93

Other funds holding FIVN

Armistice Capital's FIVN Position: Q2 2026 in Review

Armistice Capital reduced its FIVE9 (FIVN) stake by 3.5% in Q2 2026, selling an estimated $1.11M and leaving 1,536,000 shares worth $32.7M. The position accounts for 0.4% of the portfolio, ranked #38.

Armistice Capital first reported a position in FIVN in Q4 2021 and has held it in 16 quarters since. The position peaked at $80.1M in Q4 2024. 290 funds tracked by Wall St. Rank hold FIVN as of Q2 2026.

  • Armistice Capital held 1,536,000 shares of FIVE9 worth $32.7M as of Q2 2026.
  • Armistice Capital sold 56,000 FIVE9 shares in Q2 2026, an estimated $1.11M.
  • FIVE9 made up 0.4% of Armistice Capital's portfolio in Q2 2026, its #38 holding.
  • Armistice Capital first reported a position in FIVE9 in Q4 2021 and has held it in 16 quarters since.
  • Armistice Capital's FIVE9 position peaked at $80.1M in Q4 2024.
  • 290 funds tracked by Wall St. Rank held FIVE9 as of Q2 2026.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.